GBS begins with tingling or numbness in the feet and hands, followed by muscle weakness and difficulty moving joints.

US health chiefs issued a warning about RSV jabs, which were only launched in Britain last year.In the UK, the condition is ...

India's western city of Pune is battling rising cases of the Guillain-Barré Syndrome (GBS), with at least 111 identified cases just in the last three weeks, local media outlets reported on Tuesday ...

Sarclisa (isatuximab) has been approved in China for use in combination with the VRd regimen to treat newly diagnosed multiple myeloma patients w ...

First Check spoke to Dr Priyanka Sehrawat, MD Medicine, DM Neurology (AIIMS Delhi), currently working as senior Neurologist ...

Financial writer recommends Voyager Therapeutics, Inc. for high-risk investors due to promising preclinical Alzheimer's ...

Guillain-Barré Syndrome is a rare neurological disorder where the body’s immune system—which normally protects it from ...

As we age, our immune systems undergo a gradual decline in function, but there are things we can do now to help keep them ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

The FDA approved a wide range of therapies in 2024, including many new molecular entities and biological products.

R.F.K. Jr. and others have blamed the ingredient for allergies and other illnesses. Scientists say it actually bolsters the ...